ACH Accendra Health, Inc.
$0.21▲ +3.65%
Healthcare
Other
Volume 34.2K
Avg Volume (10D) 2.98M
Key Metrics & Fundamentals
Market Cap
$16.17M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.19 - 5.52
% vs 50 MA
-74.26%
% vs 200 MA
-91.12%
RSI-14
16.8
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.90
Free Cash Flow
-$74.65M
Gross Rev
$613.23M
Gross Profit
$263.41M
EBITDA
$84.90M
COGS
$349.83M
Operating Exp
$243.56M
Operating Income
$19.85M
EBIT
$19.85M
Pretax Income
-$87.63M
Net Income
-$89.07M
EPS (Diluted)
-1.16
Price & Volume History
Loading chart…
Recent News
Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call
Business Wire · Oct 22, 2026 4:05 PM ET
Accendra Health Receives NYSE Listing Notice
MT Newswires · Oct 9, 2026 5:08 PM ET
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Business Wire · Oct 9, 2026 4:05 PM ET
New Strong Sell Stocks for October 9th
Zacks · Oct 9, 2026 5:12 AM ET
New Strong Sell Stocks for October 6th
Zacks · Oct 6, 2026 2:40 AM ET
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
Business Wire · Sep 17, 2026 6:30 AM ET
Accendra Health drops equity issuance plan as CEO succession process advances
InvestorsHub · Aug 17, 2026 8:29 AM ET
Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans
Business Wire · Aug 17, 2026 6:30 AM ET
UBS Adjusts Price Target on Acadia Healthcare to $1.50 From $4.50, Keeps Neutral Rating
MT Newswires · Aug 14, 2026 9:36 AM ET
UBS Adjusts Price Target on Accendra Health to $1.50 From $4.50, Keeps Neutral Rating
MT Newswires · Aug 13, 2026 9:17 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ACH's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.